Lilly submitted the diabetes NDA in October 2021, the FDA approved Mounjaro in May 2022, and the obesity approval (Zepbound) followed in November 2023
To see if you qualify, you can start with the TrimRx intake quiz, which walks you through the eligibility criteria and connects you with a licensed California provider
Mounjaro Tirzepatide Injections for Weight Loss in Apple Valley, CA Mounjaro tirzepatide injections are capable of producing transformational weight loss effects
Even modest increases in daily movementsuch as walkingcontribute meaningfully to outcomes
Your provider will review your complete medical history, check your current health status, and look at any other medications youre taking
all subjects had an additional health condition related to obesity, and nearly 20% of them had type 2 diabetes